Answers are grounded in this paper and cite their sources.
The NCDB system permits analysis of care patterns and survival for large numbers of contemporaneous U. S. patients with relatively rare neoplasms, such as thyroid carcinoma. In this context, it represents an unsurpassed clinical tool for analyzing care, evaluating prognostic models, generating new hypotheses, and overcoming the volume-related drawbacks inherent in the study of such neoplasms. [See editorial on pages 2434-6, this issue.]
No takes yet. Share an insight, caveat, or question.
Hundahl et al. (1998) studied this question.
Synapse has enriched 10 related papers. Consider them for comparative context: